Cargando…
Predicting CK2 beta-dependent substrates using linear patterns
CK2 is a constitutively active Ser/Thr protein kinase deregulated in cancer and other pathologies, responsible for about the 20% of the human phosphoproteome. The holoenzyme is a complex composed of two catalytic (α or α´) and two regulatory (β) subunits, with individual subunits also coexisting in...
Autores principales: | Núñez de Villavicencio-Díaz, Teresa, Mazola, Yuliet, Perera Negrín, Yasser, Cruz García, Yiliam, Guirola Cruz, Osmany, Perea Rodríguez, Silvio E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668876/ https://www.ncbi.nlm.nih.gov/pubmed/29124183 http://dx.doi.org/10.1016/j.bbrep.2015.08.011 |
Ejemplares similares
-
Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
por: Rosales, Mauro, et al.
Publicado: (2021) -
Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015) -
Integrating Bioinformatics Tools to Handle Glycosylation
por: Mazola, Yuliet, et al.
Publicado: (2011) -
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
por: Rosales, Mauro, et al.
Publicado: (2021) -
Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks
por: Nuñez de Villavicencio-Diaz, Teresa, et al.
Publicado: (2017)